
Larimar Therapeutics Inc (LRMR)
NASDAQ
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -14.92M | -24.12M | -33.46M | -10.41M | -24.4M | -48.95M | -70.76M | -26.54M |
Cash from Investing Activities | 82.41M | 35.98M | 33.35M | -68.36M | -131.86M | -104.58M | -85.39M | 14.45M |
Cash from Financing Activities | N/A | 30k | 30k | 162.15M | 161.82M | 161.85M | 161.88M | N/A |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -43.78M | -51.49M | -40.78M | -42.2M | -42.11M | -27.57M | -33.46M | -70.76M |
Cash from Investing Activities | 35.65M | -6.87M | 25.26M | 17.09M | 24.17M | -90.96M | 33.35M | -85.39M |
Cash from Financing Activities | 16.56M | 66.91M | -5.26M | 93.59M | 19.89M | 75.26M | 30k | 161.88M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.